CSAR Data Set Release 2012: Ligands, Affinities, Complexes, and Docking Decoys

A major goal in drug design is the improvement of computational methods for docking and scoring. The Community Structure Activity Resource (CSAR) has collected several data sets from industry and added in-house data sets that may be used for this purpose (www.csardock.org). CSAR has currently obtain...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of chemical information and modeling 2013-08, Vol.53 (8), p.1842-1852
Hauptverfasser: Dunbar, James B, Smith, Richard D, Damm-Ganamet, Kelly L, Ahmed, Aqeel, Esposito, Emilio Xavier, Delproposto, James, Chinnaswamy, Krishnapriya, Kang, You-Na, Kubish, Ginger, Gestwicki, Jason E, Stuckey, Jeanne A, Carlson, Heather A
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1852
container_issue 8
container_start_page 1842
container_title Journal of chemical information and modeling
container_volume 53
creator Dunbar, James B
Smith, Richard D
Damm-Ganamet, Kelly L
Ahmed, Aqeel
Esposito, Emilio Xavier
Delproposto, James
Chinnaswamy, Krishnapriya
Kang, You-Na
Kubish, Ginger
Gestwicki, Jason E
Stuckey, Jeanne A
Carlson, Heather A
description A major goal in drug design is the improvement of computational methods for docking and scoring. The Community Structure Activity Resource (CSAR) has collected several data sets from industry and added in-house data sets that may be used for this purpose (www.csardock.org). CSAR has currently obtained data from Abbott, GlaxoSmithKline, and Vertex and is working on obtaining data from several others. Combined with our in-house projects, we are providing a data set consisting of 6 protein targets, 647 compounds with biological affinities, and 82 crystal structures. Multiple congeneric series are available for several targets with a few representative crystal structures of each of the series. These series generally contain a few inactive compounds, usually not available in the literature, to provide an upper bound to the affinity range. The affinity ranges are typically 3–4 orders of magnitude per series. For our in-house projects, we have had compounds synthesized for biological testing. Affinities were measured by Thermofluor, Octet RED, and isothermal titration calorimetry for the most soluble. This allows the direct comparison of the biological affinities for those compounds, providing a measure of the variance in the experimental affinity. It appears that there can be considerable variance in the absolute value of the affinity, making the prediction of the absolute value ill-defined. However, the relative rankings within the methods are much better, and this fits with the observation that predicting relative ranking is a more tractable problem computationally. For those in-house compounds, we also have measured the following physical properties: logD, logP, thermodynamic solubility, and pK a. This data set also provides a substantial decoy set for each target consisting of diverse conformations covering the entire active site for all of the 58 CSAR-quality crystal structures. The CSAR data sets (CSAR-NRC HiQ and the 2012 release) provide substantial, publically available, curated data sets for use in parametrizing and validating docking and scoring methods.
doi_str_mv 10.1021/ci4000486
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3753885</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>3059453721</sourcerecordid><originalsourceid>FETCH-LOGICAL-a562t-ee4ea1171b8b8169be9b34ea3b58ac07d3b739c2abfa614a042873d6261f7e9f3</originalsourceid><addsrcrecordid>eNqFkd1LHDEUxUOx1I_2wX9ABkRoodvmY5JMfCgsu9oWFgU_wLdwJ3tnjc5O1sms1P_erK6r1gefcsj9cXJuDiHbjP5glLOfzueU0rxQH8gGk7npGUUv1p60NGqdbMZ4RakQRvFPZJ0LxTTneoMcDU77J9kQOshOsctOsEaImHHK-H428hNoxvF71q8q3_jOY9KDMJ3V-G8h0zAbBnftm0k2RBfu4mfysYI64pfluUXODw_OBn96o-Pffwf9UQ-k4l0PMUdgTLOyKAumTImmFOlKlLIAR_VYlFoYx6GsQLEcaM4LLcaKK1ZpNJXYIr8efWfzcopjh03XQm1nrZ9Ce2cDePt60vhLOwm3VmgpikImg69LgzbczDF2duqjw7qGBsM8WpY4SSVX6n00heOaM2ESuvsfehXmbZN-4oEyMhWyoL49Uq4NMbZYrXIzaheF2lWhid15ueiKfGowAXtLAKKDumqhcT4-c1qlcEY-c-Dii1RvHrwH5t2wdg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1428955499</pqid></control><display><type>article</type><title>CSAR Data Set Release 2012: Ligands, Affinities, Complexes, and Docking Decoys</title><source>ACS Publications</source><source>MEDLINE</source><creator>Dunbar, James B ; Smith, Richard D ; Damm-Ganamet, Kelly L ; Ahmed, Aqeel ; Esposito, Emilio Xavier ; Delproposto, James ; Chinnaswamy, Krishnapriya ; Kang, You-Na ; Kubish, Ginger ; Gestwicki, Jason E ; Stuckey, Jeanne A ; Carlson, Heather A</creator><creatorcontrib>Dunbar, James B ; Smith, Richard D ; Damm-Ganamet, Kelly L ; Ahmed, Aqeel ; Esposito, Emilio Xavier ; Delproposto, James ; Chinnaswamy, Krishnapriya ; Kang, You-Na ; Kubish, Ginger ; Gestwicki, Jason E ; Stuckey, Jeanne A ; Carlson, Heather A</creatorcontrib><description>A major goal in drug design is the improvement of computational methods for docking and scoring. The Community Structure Activity Resource (CSAR) has collected several data sets from industry and added in-house data sets that may be used for this purpose (www.csardock.org). CSAR has currently obtained data from Abbott, GlaxoSmithKline, and Vertex and is working on obtaining data from several others. Combined with our in-house projects, we are providing a data set consisting of 6 protein targets, 647 compounds with biological affinities, and 82 crystal structures. Multiple congeneric series are available for several targets with a few representative crystal structures of each of the series. These series generally contain a few inactive compounds, usually not available in the literature, to provide an upper bound to the affinity range. The affinity ranges are typically 3–4 orders of magnitude per series. For our in-house projects, we have had compounds synthesized for biological testing. Affinities were measured by Thermofluor, Octet RED, and isothermal titration calorimetry for the most soluble. This allows the direct comparison of the biological affinities for those compounds, providing a measure of the variance in the experimental affinity. It appears that there can be considerable variance in the absolute value of the affinity, making the prediction of the absolute value ill-defined. However, the relative rankings within the methods are much better, and this fits with the observation that predicting relative ranking is a more tractable problem computationally. For those in-house compounds, we also have measured the following physical properties: logD, logP, thermodynamic solubility, and pK a. This data set also provides a substantial decoy set for each target consisting of diverse conformations covering the entire active site for all of the 58 CSAR-quality crystal structures. The CSAR data sets (CSAR-NRC HiQ and the 2012 release) provide substantial, publically available, curated data sets for use in parametrizing and validating docking and scoring methods.</description><identifier>ISSN: 1549-9596</identifier><identifier>EISSN: 1549-960X</identifier><identifier>DOI: 10.1021/ci4000486</identifier><identifier>PMID: 23617227</identifier><language>eng</language><publisher>Washington, DC: American Chemical Society</publisher><subject>Affinity ; Biological ; Biological and medical sciences ; Chemical compounds ; Crystal structure ; Databases, Pharmaceutical ; Docking ; Drug Design ; General pharmacology ; Internet ; Ligands ; Medical sciences ; Molecular chemistry ; Molecular Docking Simulation - methods ; Molecular structure ; Pharmaceutical technology. Pharmaceutical industry ; Pharmacology. Drug treatments ; Physicochemical properties. Structure-activity relationships ; Protein Binding ; Protein Conformation ; Proteins ; Ranking ; Scoring ; Structure-Activity Relationship ; Thermodynamics ; Variance</subject><ispartof>Journal of chemical information and modeling, 2013-08, Vol.53 (8), p.1842-1852</ispartof><rights>Copyright © 2013 American Chemical Society</rights><rights>2014 INIST-CNRS</rights><rights>Copyright American Chemical Society Aug 26, 2013</rights><rights>Copyright © 2013 American Chemical Society 2013 American Chemical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a562t-ee4ea1171b8b8169be9b34ea3b58ac07d3b739c2abfa614a042873d6261f7e9f3</citedby><cites>FETCH-LOGICAL-a562t-ee4ea1171b8b8169be9b34ea3b58ac07d3b739c2abfa614a042873d6261f7e9f3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/ci4000486$$EPDF$$P50$$Gacs$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/ci4000486$$EHTML$$P50$$Gacs$$Hfree_for_read</linktohtml><link.rule.ids>230,314,776,780,881,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=27682795$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/23617227$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Dunbar, James B</creatorcontrib><creatorcontrib>Smith, Richard D</creatorcontrib><creatorcontrib>Damm-Ganamet, Kelly L</creatorcontrib><creatorcontrib>Ahmed, Aqeel</creatorcontrib><creatorcontrib>Esposito, Emilio Xavier</creatorcontrib><creatorcontrib>Delproposto, James</creatorcontrib><creatorcontrib>Chinnaswamy, Krishnapriya</creatorcontrib><creatorcontrib>Kang, You-Na</creatorcontrib><creatorcontrib>Kubish, Ginger</creatorcontrib><creatorcontrib>Gestwicki, Jason E</creatorcontrib><creatorcontrib>Stuckey, Jeanne A</creatorcontrib><creatorcontrib>Carlson, Heather A</creatorcontrib><title>CSAR Data Set Release 2012: Ligands, Affinities, Complexes, and Docking Decoys</title><title>Journal of chemical information and modeling</title><addtitle>J. Chem. Inf. Model</addtitle><description>A major goal in drug design is the improvement of computational methods for docking and scoring. The Community Structure Activity Resource (CSAR) has collected several data sets from industry and added in-house data sets that may be used for this purpose (www.csardock.org). CSAR has currently obtained data from Abbott, GlaxoSmithKline, and Vertex and is working on obtaining data from several others. Combined with our in-house projects, we are providing a data set consisting of 6 protein targets, 647 compounds with biological affinities, and 82 crystal structures. Multiple congeneric series are available for several targets with a few representative crystal structures of each of the series. These series generally contain a few inactive compounds, usually not available in the literature, to provide an upper bound to the affinity range. The affinity ranges are typically 3–4 orders of magnitude per series. For our in-house projects, we have had compounds synthesized for biological testing. Affinities were measured by Thermofluor, Octet RED, and isothermal titration calorimetry for the most soluble. This allows the direct comparison of the biological affinities for those compounds, providing a measure of the variance in the experimental affinity. It appears that there can be considerable variance in the absolute value of the affinity, making the prediction of the absolute value ill-defined. However, the relative rankings within the methods are much better, and this fits with the observation that predicting relative ranking is a more tractable problem computationally. For those in-house compounds, we also have measured the following physical properties: logD, logP, thermodynamic solubility, and pK a. This data set also provides a substantial decoy set for each target consisting of diverse conformations covering the entire active site for all of the 58 CSAR-quality crystal structures. The CSAR data sets (CSAR-NRC HiQ and the 2012 release) provide substantial, publically available, curated data sets for use in parametrizing and validating docking and scoring methods.</description><subject>Affinity</subject><subject>Biological</subject><subject>Biological and medical sciences</subject><subject>Chemical compounds</subject><subject>Crystal structure</subject><subject>Databases, Pharmaceutical</subject><subject>Docking</subject><subject>Drug Design</subject><subject>General pharmacology</subject><subject>Internet</subject><subject>Ligands</subject><subject>Medical sciences</subject><subject>Molecular chemistry</subject><subject>Molecular Docking Simulation - methods</subject><subject>Molecular structure</subject><subject>Pharmaceutical technology. Pharmaceutical industry</subject><subject>Pharmacology. Drug treatments</subject><subject>Physicochemical properties. Structure-activity relationships</subject><subject>Protein Binding</subject><subject>Protein Conformation</subject><subject>Proteins</subject><subject>Ranking</subject><subject>Scoring</subject><subject>Structure-Activity Relationship</subject><subject>Thermodynamics</subject><subject>Variance</subject><issn>1549-9596</issn><issn>1549-960X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2013</creationdate><recordtype>article</recordtype><sourceid>N~.</sourceid><sourceid>EIF</sourceid><recordid>eNqFkd1LHDEUxUOx1I_2wX9ABkRoodvmY5JMfCgsu9oWFgU_wLdwJ3tnjc5O1sms1P_erK6r1gefcsj9cXJuDiHbjP5glLOfzueU0rxQH8gGk7npGUUv1p60NGqdbMZ4RakQRvFPZJ0LxTTneoMcDU77J9kQOshOsctOsEaImHHK-H428hNoxvF71q8q3_jOY9KDMJ3V-G8h0zAbBnftm0k2RBfu4mfysYI64pfluUXODw_OBn96o-Pffwf9UQ-k4l0PMUdgTLOyKAumTImmFOlKlLIAR_VYlFoYx6GsQLEcaM4LLcaKK1ZpNJXYIr8efWfzcopjh03XQm1nrZ9Ce2cDePt60vhLOwm3VmgpikImg69LgzbczDF2duqjw7qGBsM8WpY4SSVX6n00heOaM2ESuvsfehXmbZN-4oEyMhWyoL49Uq4NMbZYrXIzaheF2lWhid15ueiKfGowAXtLAKKDumqhcT4-c1qlcEY-c-Dii1RvHrwH5t2wdg</recordid><startdate>20130826</startdate><enddate>20130826</enddate><creator>Dunbar, James B</creator><creator>Smith, Richard D</creator><creator>Damm-Ganamet, Kelly L</creator><creator>Ahmed, Aqeel</creator><creator>Esposito, Emilio Xavier</creator><creator>Delproposto, James</creator><creator>Chinnaswamy, Krishnapriya</creator><creator>Kang, You-Na</creator><creator>Kubish, Ginger</creator><creator>Gestwicki, Jason E</creator><creator>Stuckey, Jeanne A</creator><creator>Carlson, Heather A</creator><general>American Chemical Society</general><scope>N~.</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7SC</scope><scope>7SR</scope><scope>7U5</scope><scope>8BQ</scope><scope>8FD</scope><scope>JG9</scope><scope>JQ2</scope><scope>L7M</scope><scope>L~C</scope><scope>L~D</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20130826</creationdate><title>CSAR Data Set Release 2012: Ligands, Affinities, Complexes, and Docking Decoys</title><author>Dunbar, James B ; Smith, Richard D ; Damm-Ganamet, Kelly L ; Ahmed, Aqeel ; Esposito, Emilio Xavier ; Delproposto, James ; Chinnaswamy, Krishnapriya ; Kang, You-Na ; Kubish, Ginger ; Gestwicki, Jason E ; Stuckey, Jeanne A ; Carlson, Heather A</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a562t-ee4ea1171b8b8169be9b34ea3b58ac07d3b739c2abfa614a042873d6261f7e9f3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2013</creationdate><topic>Affinity</topic><topic>Biological</topic><topic>Biological and medical sciences</topic><topic>Chemical compounds</topic><topic>Crystal structure</topic><topic>Databases, Pharmaceutical</topic><topic>Docking</topic><topic>Drug Design</topic><topic>General pharmacology</topic><topic>Internet</topic><topic>Ligands</topic><topic>Medical sciences</topic><topic>Molecular chemistry</topic><topic>Molecular Docking Simulation - methods</topic><topic>Molecular structure</topic><topic>Pharmaceutical technology. Pharmaceutical industry</topic><topic>Pharmacology. Drug treatments</topic><topic>Physicochemical properties. Structure-activity relationships</topic><topic>Protein Binding</topic><topic>Protein Conformation</topic><topic>Proteins</topic><topic>Ranking</topic><topic>Scoring</topic><topic>Structure-Activity Relationship</topic><topic>Thermodynamics</topic><topic>Variance</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Dunbar, James B</creatorcontrib><creatorcontrib>Smith, Richard D</creatorcontrib><creatorcontrib>Damm-Ganamet, Kelly L</creatorcontrib><creatorcontrib>Ahmed, Aqeel</creatorcontrib><creatorcontrib>Esposito, Emilio Xavier</creatorcontrib><creatorcontrib>Delproposto, James</creatorcontrib><creatorcontrib>Chinnaswamy, Krishnapriya</creatorcontrib><creatorcontrib>Kang, You-Na</creatorcontrib><creatorcontrib>Kubish, Ginger</creatorcontrib><creatorcontrib>Gestwicki, Jason E</creatorcontrib><creatorcontrib>Stuckey, Jeanne A</creatorcontrib><creatorcontrib>Carlson, Heather A</creatorcontrib><collection>American Chemical Society (ACS) Open Access</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Computer and Information Systems Abstracts</collection><collection>Engineered Materials Abstracts</collection><collection>Solid State and Superconductivity Abstracts</collection><collection>METADEX</collection><collection>Technology Research Database</collection><collection>Materials Research Database</collection><collection>ProQuest Computer Science Collection</collection><collection>Advanced Technologies Database with Aerospace</collection><collection>Computer and Information Systems Abstracts – Academic</collection><collection>Computer and Information Systems Abstracts Professional</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of chemical information and modeling</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Dunbar, James B</au><au>Smith, Richard D</au><au>Damm-Ganamet, Kelly L</au><au>Ahmed, Aqeel</au><au>Esposito, Emilio Xavier</au><au>Delproposto, James</au><au>Chinnaswamy, Krishnapriya</au><au>Kang, You-Na</au><au>Kubish, Ginger</au><au>Gestwicki, Jason E</au><au>Stuckey, Jeanne A</au><au>Carlson, Heather A</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>CSAR Data Set Release 2012: Ligands, Affinities, Complexes, and Docking Decoys</atitle><jtitle>Journal of chemical information and modeling</jtitle><addtitle>J. Chem. Inf. Model</addtitle><date>2013-08-26</date><risdate>2013</risdate><volume>53</volume><issue>8</issue><spage>1842</spage><epage>1852</epage><pages>1842-1852</pages><issn>1549-9596</issn><eissn>1549-960X</eissn><abstract>A major goal in drug design is the improvement of computational methods for docking and scoring. The Community Structure Activity Resource (CSAR) has collected several data sets from industry and added in-house data sets that may be used for this purpose (www.csardock.org). CSAR has currently obtained data from Abbott, GlaxoSmithKline, and Vertex and is working on obtaining data from several others. Combined with our in-house projects, we are providing a data set consisting of 6 protein targets, 647 compounds with biological affinities, and 82 crystal structures. Multiple congeneric series are available for several targets with a few representative crystal structures of each of the series. These series generally contain a few inactive compounds, usually not available in the literature, to provide an upper bound to the affinity range. The affinity ranges are typically 3–4 orders of magnitude per series. For our in-house projects, we have had compounds synthesized for biological testing. Affinities were measured by Thermofluor, Octet RED, and isothermal titration calorimetry for the most soluble. This allows the direct comparison of the biological affinities for those compounds, providing a measure of the variance in the experimental affinity. It appears that there can be considerable variance in the absolute value of the affinity, making the prediction of the absolute value ill-defined. However, the relative rankings within the methods are much better, and this fits with the observation that predicting relative ranking is a more tractable problem computationally. For those in-house compounds, we also have measured the following physical properties: logD, logP, thermodynamic solubility, and pK a. This data set also provides a substantial decoy set for each target consisting of diverse conformations covering the entire active site for all of the 58 CSAR-quality crystal structures. The CSAR data sets (CSAR-NRC HiQ and the 2012 release) provide substantial, publically available, curated data sets for use in parametrizing and validating docking and scoring methods.</abstract><cop>Washington, DC</cop><pub>American Chemical Society</pub><pmid>23617227</pmid><doi>10.1021/ci4000486</doi><tpages>11</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 1549-9596
ispartof Journal of chemical information and modeling, 2013-08, Vol.53 (8), p.1842-1852
issn 1549-9596
1549-960X
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3753885
source ACS Publications; MEDLINE
subjects Affinity
Biological
Biological and medical sciences
Chemical compounds
Crystal structure
Databases, Pharmaceutical
Docking
Drug Design
General pharmacology
Internet
Ligands
Medical sciences
Molecular chemistry
Molecular Docking Simulation - methods
Molecular structure
Pharmaceutical technology. Pharmaceutical industry
Pharmacology. Drug treatments
Physicochemical properties. Structure-activity relationships
Protein Binding
Protein Conformation
Proteins
Ranking
Scoring
Structure-Activity Relationship
Thermodynamics
Variance
title CSAR Data Set Release 2012: Ligands, Affinities, Complexes, and Docking Decoys
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-10T17%3A23%3A27IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=CSAR%20Data%20Set%20Release%202012:%20Ligands,%20Affinities,%20Complexes,%20and%20Docking%20Decoys&rft.jtitle=Journal%20of%20chemical%20information%20and%20modeling&rft.au=Dunbar,%20James%20B&rft.date=2013-08-26&rft.volume=53&rft.issue=8&rft.spage=1842&rft.epage=1852&rft.pages=1842-1852&rft.issn=1549-9596&rft.eissn=1549-960X&rft_id=info:doi/10.1021/ci4000486&rft_dat=%3Cproquest_pubme%3E3059453721%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1428955499&rft_id=info:pmid/23617227&rfr_iscdi=true